New Directions for Women Inc
-
Services:
- Commission on Accreditation of Rehabilitation Facilities (CARF)
- State Substance use treatment agency
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Suicide prevention services
- Transportation assistance
- Domestic violence services, including family or partner
- Acupuncture
- Mental health services
- Integrated primary care services
- Social skills development
- Case management service
- Private non-profit organization
- Outcome follow-up after discharge
- Aftercare/continuing care
- Naloxone and overdose education
- Discharge Planning
- Breathalyzer or blood alcohol testing
- STD testing
- TB screening
- Drug or alcohol urine screening
- HIV testing
- Private health insurance
- Cash or self-payment
- IHS/Tribal/Urban (ITU) funds
- Assistance with obtaining social services
- Self-help groups
- Mentoring/peer support
- Housing services
- Adult women
- Clients with co-occurring mental and substance use disorders
- Clients who have experienced trauma
- Clients with co-occurring pain and substance use disorders
- Substance use disorder counseling
- Relapse prevention
- Cognitive behavioral therapy
- Telemedicine/telehealth therapy
- Trauma-related counseling
- Contingency management/motivational incentives
- 12-step facilitation
- Motivational interviewing
- Brief intervention
- Vaping permitted in designated area
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Seniors
- Young Adults
- Adults
- Cocaine Detoxification
- Benzodiazepines Detoxification
- Medication routinely used during detoxification
- Opioids detoxification
- Alcohol Detoxification
- Methamphetamines detoxification
- Acamprosate (Campral®)
- Disulfiram
- Medications for Hepatitis C treatment
- Medication for mental disorders
- Clonidine
- Lofexidine
- Non-nicotine smoking/tobacco cessation
- Buprenorphine (extended-release, injectable)
- Naltrexone (extended-release, injectable)
- Naltrexone (oral)
- Buprenorphine without naloxone
- Buprenorphine with naloxone
- Long-term residential
- Residential/24-hour residential
- Residential detoxification
- Short-term residential
- Smoking permitted in designated area
- Individual counseling
- Vocational training or educational support (for example, high school coursework, GED preparation, etc.)
- Substance use disorder education
- HIV or AIDS education, counseling, or support
- Marital/couples counseling
- Family counseling
- Hepatitis education, counseling, or support
- Group counseling
- Health education services other than HIV/AIDS or hepatitis
- Screening for tobacco use
- Outreach to persons in the community
- Screening for substance use
- Comprehensive substance use assessment
- Screening for mental disorders
- Complete medical history/physical exam
- Buprenorphine detoxification
- Prescribes naltrexone
- Lofexidine or Clonidine detoxification
- Accepts clients using MAT but prescribed elsewhere
- Prescribes buprenorphine
- Buprenorphine maintenance
- Other contracted prescribing entity
- In-network prescribing entity
- Other contracted prescribing entity
- In-network prescribing entity
- Detoxification
- Substance use treatment
- Female
License/Certification/Accreditation
Opioid Medications used in Treatment
Ancillary Services
Facility Operation (e.g., Private, Public)
Transitional Services
Testing
Payment/Insurance/Funding Accepted
Recovery Support Services
Special Programs/Groups Offered
Treatment Approaches
Facility Vaping Policy
Type of Alcohol Use Disorder Treatment
Age Groups Accepted
Detoxification (medical withdrawal) Services
Pharmacotherapies
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Facility Smoking Policy
Education and Counseling Services
Assessment/Pre-treatment
Type of Opioid Treatment
External Opioid Medications Source
External Source of Medications Used for Alcohol Use Disorder Treatment
Type of Care
Gender Accepted